Drugs / PN2034
last change Aug 2007 re-read 2 minutes ago

PN2034

Developed for
type 2 diabetes mellitus
Investigated by
Wellstat Therapeutics

Trials 2 · a red edge is where a trial was stopped

20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00110864 May 2005 → Apr 2007 type 2 diabetes mellitus Wellstat Therapeutics Completed No outcome recorded
Phase 2 NCT00110851 Apr 2005 → Aug 2007 type 2 diabetes mellitus Wellstat Therapeutics Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as PN2034 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00110851
1

NCT00110864